Belzutifan is a hypoxia-inducible factor-2α inhibitor that is US FDA approved for the treatment of VHL disease-associated renal cell carcinoma (RCC), CNS hemangioblastomas, or pancreatic ...

Investigators analyzed blood samples from patients on dialysis to study uremic toxins in association with renal anemia pathogenesis.

(HealthDay News) — Neither delivery of electronic nudge letters nor letters to general practice increase uptake of guideline-directed medical therapy (GDMT) among patients with chronic kidney disease ...

The first trial of adjuvant platinum-based chemotherapy plus paclitaxel in patients with high-risk penile cancer provided some insights.

Unvaccinated patients had higher rate of continuous renal replacement therapy during hospitalization and higher rate of being discharged on RRT.

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

(HealthDay News) — Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online June 17 in Heart.

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

More than half (57.4%) of respondents reported ever using cannabis through smoking, vaping, dabbing, or ingesting edibles. Of respondents with data evaluable on forms of lifetime cannabis use, 28. ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy. (HealthDay News) — For cancer patients with a major depressive ...